Inquiry Basket
Loading ......
Powassan virus (POWV) represents one of the most significant emerging tick-borne flaviviruses in North America and parts of Asia. While far less common than Lyme disease, the clinical stakes associated with POWV are exponentially higher, often resulting in severe neuroinvasive disease, permanent neurological sequelae, or death. As climate change expands the geographical range of its primary vectors—Ixodes cookei and Ixodes scapularis—the medical and scientific communities are facing an urgent need to deconstruct the virus's molecular mechanisms and identify viable therapeutic interventions. Unlike many other tick-borne pathogens that require hours of attachment to transmit, POWV can be transmitted to a host within minutes of a tick bite, making traditional prevention methods like "tick checks" significantly less effective.
Figure 1. Neuroinvasion of Powassan virus (POW) and Deer tick virus (DTV) in humans and mice.( Ebel G D,2010)
Powassan virus is a member of the Flaviviridae family, specifically within the Tick-Borne Encephalitis Virus (TBEV) serogroup. Structurally, it is an enveloped, spherical virus approximately 50 nm in diameter. The POWV genome consists of a single-stranded, positive-sense RNA of approximately 11 kb. This genome encodes a single polyprotein that is subsequently cleaved by viral and host proteases into three structural proteins and seven non-structural (NS) proteins:
Structural Proteins: C (Capsid), prM/M (Pre-membrane/Membrane), and E (Envelope). The E protein is the primary driver of receptor binding and membrane fusion.
Non-Structural Proteins: NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5. These proteins are responsible for viral replication, polyprotein processing, and, crucially, the evasion of the host immune response.
The following targets are critical for POWV replication, pathogenesis, and host interactions, making them promising candidates for therapeutic development and research focus:
| Pathological Changes | Details |
| TIM-1 (T-cell immunoglobulin and mucin domain-containing protein 1) | A phosphatidylserine (PtdSer) receptor that mediates POWV entry into host cells. POWV binds to TIM-1 via PtdSer on its envelope, facilitating viral adsorption and membrane fusion. Soluble TIM-1 protein can effectively block POWV infection, highlighting its potential as a therapeutic target. TIM-1 is expressed on the surface of neurons, hBMECs, and pericytes—key cell types targeted by POWV—and its expression correlates with viral tropism. |
| AXL Receptor Tyrosine Kinase | Another PtdSer receptor that promotes POWV entry, alongside TIM-1. AXL interacts with POWV envelope proteins, mediating viral internalization into host cells. Like TIM-1, AXL is expressed on CNS cells and is critical for viral invasion of the brain. In vivo studies in mice and in vitro studies using cortical organoids have confirmed that AXL-positive cells are highly susceptible to POWV infection. |
| STAT1/STAT2 (Signal Transducers and Activators of Transcription 1/2) | Host transcription factors that play a central role in the IFN signaling pathway, which is critical for the host's innate immune response to POWV. POWV modulates STAT1/STAT2 activity to suppress IFN-β and ISG expression, allowing the virus to evade antiviral defenses. Persistent POWV infection in hBMECs and pericytes is associated with impaired STAT1/STAT2 activation, highlighting the importance of this pathway in controlling viral infection. |
| Interferon-β (IFN-β) | A key cytokine that induces the expression of ISGs with antiviral activity. POWV infection induces IFN-β expression in host cells, but the virus delays IFN-β secretion in pericytes and modulates ISG expression to promote persistent infection. Enhancing IFN-β signaling or administering exogenous IFN-β may represent a potential therapeutic strategy to inhibit POWV replication. |
POWV is endemic to North America and parts of Eurasia, with the majority of human cases reported in the northeastern and upper midwestern United States, Canada, and Russia. The primary transmission vector is ixodid ticks, with Ixodes scapularis (deer tick) being the most important vector for POWV-II in the United States, and Ixodes cookei and Ixodes marxi serving as vectors for POWV-I. The prevalence of POWV in Ixodes scapularis ticks in the northeastern United States is approximately 2%, indicating a significant risk of human exposure.
Human POWV cases are relatively rare but have been increasing in recent years. From 2004 to 2024, a total of 397 cases were reported in the United States, with 50 deaths, and nearly half of these cases occurred in the past five years. Massachusetts has the second-highest number of cases (71) during this period, second only to Minnesota. Risk factors for infection include outdoor activities in tick-infested areas (e.g., hiking, camping, gardening), as well as exposure to ticks in residential areas. There is no evidence of human-to-human transmission of POWV.
The incubation period for POWV ranges from 1 to 4 weeks. Clinically, the disease is often biphasic. The initial prodromal phase presents with non-specific symptoms: fever, headache, vomiting, and generalized weakness. For many, the infection resolves here. However, in neuroinvasive cases, the virus progresses to the CNS, manifesting as:
Diagnosis is notoriously difficult. Routine blood work often shows normal or slightly elevated white blood cell counts. The gold standard for diagnosis is IgM serology in the serum or cerebrospinal fluid (CSF), typically via Enzyme-Linked Immunosorbent Assay (ELISA). However, cross-reactivity with other flaviviruses (like West Nile or Dengue) is a common confounding factor, requiring confirmation through a Plaque Reduction Neutralization Test (PRNT).
Powassan virus is a high-consequence pathogen that occupies a dangerous niche in the landscape of infectious diseases. Its rapid transmission, neurotropic nature, and sophisticated mechanisms for evading the host's innate immune response make it a formidable challenge. While the identification of molecular targets like the NS5 polymerase and the E protein fusion loop provides a roadmap for drug discovery, the immediate priority remains clinical awareness and aggressive vector control. As we move deeper into an era of environmental change, deconstructing the host-virus interactions of POWV will be essential to preventing this rare virus from becoming a common tragedy.
Reference
| Target | Cat. No. | Product Name | Host | Isotype | Application | |
| POWV prM | CABT-ZS1011 | Magic™ Rabbit Anti-POWV prM Polyclonal antibody | Rabbit | IgG | WB | Inquiry |
| POWV | CABT-ZS5006 | Rabbit Anti-Powassan virus prM protein polyclonal antibody | Rabbit | IgG | WB, ICC/IF, IHC-P, IHC-F | Inquiry |
| POWV E | CABT-CS1008 | Mouse Anti-POWV E domain III Monoclonal antibody, clone POWV91 | Mouse | IgG2c | Neut, ELISA, FC | Inquiry |
| CABT-CS1009 | Rabbit Anti-POWV E domain III Monoclonal antibody, clone POWV91 | Rabbit | IgG | Neut, ELISA, FC | Inquiry | |
| POWV NS1 | CABT-RM244 | Magic™ Mouse Anti-POWV NS1 Monoclonal antibody, clone 3ZQP6 | Mouse | IgG2a | ELISA (cap), LFIA | Inquiry |
| CABT-RM245 | Magic™ Mouse Anti-POWV NS1 Monoclonal antibody, clone RCV73 | Mouse | IgG2a | ELISA (det), LFIA | Inquiry |
| Target | Cat. No. | Product Name | Host | |
| POWV NS1 | DAGC026 | Recombinant Powassan Virus NS1 Protein [His] | HEK293 cells | Inquiry |
| POWV | DAG-WT5844 | Recombinant Deer tick virus Envelope protein [His] | HEK293 cells | Inquiry |
| DAG-WT1201 | Recombinant Powassan virus prM/M [GST, His] | E. coli | Inquiry |
Loading ......
